Last week, we were honored to host Ph.D. trainees and postdocs from myCHOICE at UChicagoGRAD at our Cambridge, MA office. It was great to meet everyone and have the opportunity to share more about our company, our science, and career paths across biotech! #DaretoBeam #BeamTeam
Beam Therapeutics
Biotechnology Research
Cambridge, Massachusetts 86,244 followers
Our vision is to provide life-long cures for patients suffering from serious diseases.
About us
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes. Our dream is to provide life-long cures for patients suffering from serious diseases. The Beam Team Is: • A community of fearless innovators • Rigorous and honest in our research • Listening with open minds • Committed to each other
- Website
-
http://beamtx.com
External link for Beam Therapeutics
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2017
- Specialties
- gene therapy, base editing, gene editing, precision medicines, CRISPR, CRISPR Cas9, genetic diseases, rare diseases, hematology, lipid nanoparticles, LNP, vector production, AAV, In vivo, ex vivo, Liver, mRNA Production, mRNA, DNA, RNA, Cas9, drug development, drug delivery, immunology, formulation development, virology, viral delivery, nanoparticles formulation, structural biology, cell biology, protein sciences, and cell therapy
Locations
-
Primary
Get directions
238 Main St
Cambridge, Massachusetts 02142, US
Employees at Beam Therapeutics
Updates
-
The Cambridge #BeamTeam recently had the opportunity to take part in a Mending Workshop hosted by our Sustainability team, where we learned how to repair old clothes in an effort to be intentionally low-waste. It’s always great to learn new skills, especially if it helps each of us minimize our carbon footprint. #DaretoBeam
-
-
Today, Beam reported second quarter 2026 financial results and provided updates across the company’s hematology and genetic disease franchises. Read the press release here: https://lnkd.in/g3_Qkvc5 #BeamTeam #DaretoBeam
-
-
The #BeamTeam had a great time at the Massachusetts Sickle Cell Association's annual Red Ribbon Gala! The gala benefits essential programs and services to individuals living with #sicklecelldisease throughout Massachusetts, and it’s always a joy to sponsor and attend. #DaretoBeam
-
-
On a recent SpreadLoveio podcast episode, Beam’s Chief Medical Officer Amy Simon speaks about the #BeamTeam’s culture, insights on leadership, and the human side of healthcare. Hear more from Amy in the podcast episode linked below.
Leadership isn’t about having all the answers. It’s about staying curious, creating trust, and never stopping your own growth. I loved this conversation with Amy Simon, Chief Medical Officer at Beam. We talked about humility, psychological safety, innovation, and what it takes to lead when you’re building the future of medicine. One quote that stayed with me: “Leadership is a work in progress.” I hope you enjoy it as much as I did. 🎙️ https://lnkd.in/ez6P3DDF
-
What’s your ‘why’? At Beam, our mission fuels our team to keep patients at the center of everything we do. Learn more about why Vice President of Patient Operations Rosanna Ferrante resonates with our mission. If you’d like to join her growing team, apply for the open Gene Therapy Operations Director roles here: https://lnkd.in/giSzPpD3 #DaretoBeam #BeamTeam
-
-
Nothing says summer in Boston like a day at Fenway Park! The #BeamTeam had a great time together at the Red Sox game last week, made even better with a win that was part of the Red Sox's record-tying streak! #DaretoBeam
-
-
We’re looking for an Associate Director/Director, Toxicology to join our growing Non-Clinical Development team! If you want to be part of a patient-focused, innovative, and upstanding team, we’d love for you to apply: https://lnkd.in/g7ig7Dq5 #DaretoBeam #BeamTeam
-
We’re happy to sponsor National PKU Alliance's upcoming “Living Our Best PKU Life” community conference on July 16! This is a great opportunity for those impacted by PKU, industry partners, researchers, and clinicians to come together to learn, share information, and connect. Learn more about the event here: https://lnkd.in/eCmSWD5S #DaretoBeam #PKU
-
-
Hear from Beam’s Senior Director, Market Access Maria Graesser Pote, JD on why she joined the #BeamTeam! If you’re interested in joining the Beam team, Maria is growing her team of Field Market Access Directors across the U.S. Learn more here: beamtx.com/jobs
-